©The Author(s) 2025.
World J Gastrointest Endosc. Oct 16, 2025; 17(10): 107840
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.107840
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.107840
Table 3 Complication rates and risk factors in gastric endoscopic submucosal dissection
| Ref. | Country of origin | Intraoperative perforation | Delayed bleeding | Stricture risk |
| Hatta et al[38] | Japan | - | 4.7%-5.0% | - |
| RFs: Chronic kidney disease with hemodialysis, antithrombotic agents (aspirin, P2Y12RA, cilostazol, warfin, DOAC), multiple tumors, tumor size > 30 mm, tumor location in lower third | ||||
| Suzuki et al[87] | Japan | 2.3% | 4.4% | - |
| Zullo et al[86] | Western countries | 3.1% | 5.8% | - |
| Yano et al[32] | Japan | - | 8.5% (7.3% in the first 5 days) | - |
| RFs in first 5 days: Tumor location in the distal stomach, expanded indications or non-indicated lesions, a specimen diameter of ≥ 40 mm, and antithrombotic therapy | ||||
| Risk factors after 5 days: Tumor location in the proximal stomach, hemodialysis, and antithrombotic therapy | ||||
| Okada et al[37] | Japan | - | 4.81% | - |
| RFs in first 4 days: Size of the specimen, tumor location in the lower third of the stomach | ||||
| Risk factors after 4 days: Size of the specimen, tumor location in the middle third of the stomach, hypertension, high body mass index (≥ 25 kg/m2) | ||||
| Miyahara et al[29] | Japan | 3.7% | 6.9% | - |
| RFs: Tumor location, massive submucusal invasion, endoscopists’ experience of 100-149 cases and hypertension | RFs: Tumor location, tumor size, and scarred lesion | |||
| Toyokawa et al[30] | Japan | 2.4% | 5.0% | - |
| RFs: Location in the upper area of the stomach | Risk factors: Age ≥ 80 years, long procedure time | |||
| Nam et al[31] | South Korea | - | 4.1% | - |
| RFs in the first 24 hours: Age ≤ 65 years, resection size ≥ 30 mm, procedure time ≥ 20 minutes, lower third of the stomach, erosion, clopidogrel use | ||||
| RFs after 24 hours: The middle to upper third of the stomach, undifferentiated carcinoma, erosion, high risk of stigma during second-look endoscopy, history of early PEB, clopidogrel use | ||||
| Sumiyoshi et al[155] | Japan | - | - | Cardia: 21.3% |
| Antrum: 3.2% | ||||
| RFs: More than 75% of the circumferential extent (both locations) | ||||
| Coda et al[156] | Japan | - | - | Cardia: 17% |
| Pyloric: 7% | ||||
| RF: Circumferential extent > 75%, longitudinal extent > 5 cm |
- Citation: Spychalski M, Orzeszko Z, Kasprzyk P. Advancements in endoscopic closure: Embracing a new era of managing complications and postprocedural defects after endoscopic submucosal dissection. World J Gastrointest Endosc 2025; 17(10): 107840
- URL: https://www.wjgnet.com/1948-5190/full/v17/i10/107840.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i10.107840